Stockreport

Actio Biosciences Appoints Ben Cravatt, Ph.D., to Board of Directors [Yahoo! Finance]

BAYER AG S/ADR  (BAYRY) 
NASDAQ:AMEX Investor Relations: investor.bayer.com
PDF medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, today announced that Ben Cravatt, Ph.D., has joined the comp [Read more]